Genome-Wide Association Study Identifies Variants Associated With Histologic Features of Nonalcoholic Fatty Liver Disease-Reference-Cited by-同舟云学术

Genome-Wide Association Study Identifies Variants Associated With Histologic Features of Nonalcoholic Fatty Liver Disease

Published:2010-11 Issue:5 Volume:139 Page:1567-1576.e6
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Chalasani Naga,Guo Xiuqing,Loomba Rohit,Goodarzi Mark O.,Haritunians Talin,Kwon Soonil,Cui Jinrui,Taylor Kent D.,Wilson Laura,Cummings Oscar W.,Chen Yii-Der Ida,Rotter Jerome I.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference44 articles.

1. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity;Browning;Hepatology,2004

2. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis;Angulo;Hepatology,1999

3. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity;Matteoni;Gastroenterology,1999

4. Familial aggregation of insulin resistance in first-degree relatives of patients with nonalcoholic fatty liver disease;Abdelmalek;Clin Gastroenterol Hepatol,2006

5. Parental obesity and offspring serum alanine and aspartate aminotransferase levels: the Framingham heart study;Loomba;Gastroenterology,2008

Cited by 279 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genome−wide association analysis to search for new loci associated with stroke risk in Northwestern Chinese population;Gene;2024-11

2. Genetic risk accentuates dietary effects on hepatic steatosis, inflammation and fibrosis in a population-based cohort;Journal of Hepatology;2024-09

3. Serum proteome signatures associated with liver steatosis in adolescents with obesity;Journal of Endocrinological Investigation;2024-07-17

4. Differential Effects of Genetic Polymorphism on Comorbid Disease in Metabolic Dysfunction–Associated Steatotic Liver Disease;Clinical Gastroenterology and Hepatology;2024-07

5. Clinical and genetic risk factors for progressive fibrosis in metabolic dysfunction–associated steatotic liver disease;Hepatology Communications;2024-07